Lilly in the United Kingdom

Lilly UK became our first affiliate business to open outside of the US in 1934, with our UK HQ located in Basingstoke.

For 90 years, we have remained committed to bringing life-changing, innovative medicines to UK patients. We currently market 23 medicines in the UK and have more than 60 potential medicines currently in development.

Our UK operations have played a central role in our company’s global development. We have around 570 talented employees across the UK, working in roles such as regulatory affairs, medical affairs, marketing and communications.

Powered By Partnerships

We work in close partnership with NHS, government, academia and patient groups to accelerate the delivery of innovative treatments, refine patient care pathways and achieve improved health outcomes. By combining our expertise, experience and resources, we can deliver the best possible healthcare for patients in the UK.

Driven by Innovation

Between 2019 and end of 2023, we have invested £535 million in our UK research operations. We currently have 50 clinical trials ongoing across 260 study locations, in areas including diabetes, oncology, immunotherapy, pain and neurodegeneration. We are proud that our work in the UK has been awarded both the Prix Galien and the Queen's Award for Innovation.

Broadening our Impact

We are committed to playing an active role in our local communities. In Basingstoke, we are proud to work closely with Destination Basingstoke (a not-for-profit company, managing a portfolio of showcase events for the local area), and are proud to sponsor headline events including the Basingstoke Half Marathon. A number of our employees have taken part in the races, and we were thrilled to win the “Corporate Challenge” in 2019.

Lilly’s Global Day of Service is one of the largest single day volunteer programs in the world. In the UK, our employees volunteer with a number of different organisations including local schools, charities and community groups.

2023 data unless stated otherwise